Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 14/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.59 |
| ▸ | HPGD | P15428 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | GLA | P06280 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 3/20 | 0.59 |
| ▸ | ATM | Q13315 | 3/20 | 0.59 |
| ▸ | CASP1 | P29466 | 1/20 | 0.59 |
| ▸ | CASP7 | P55210 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | XDH | P47989 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6644845 | 0.90 | KDM4E (0.47) | KDM4EALDH1A1HSD17B10HPGDMAPT | |
| SCHEMBL31455673 | 0.90 | KDM4E (0.47) | KDM4EALDH1A1HSD17B10HPGDMAPT | |
| SCHEMBL1730549 | 0.90 | KDM4E (0.47) | KDM4EALDH1A1HSD17B10HPGDMAPT | |
| SCHEMBL6647697 | 0.87 | KDM4E (0.45) | KDM4EALDH1A1HSD17B10HPGDMAPT | |
| SCHEMBL122553 | 0.86 | KDM4E (0.54) | KDM4EALDH1A1HSD17B10HPGDMAPT | |
| SCHEMBL8200995 | 0.83 | KDM4E (0.46) | KDM4EALDH1A1HSD17B10HPGDMAPT | |
| SCHEMBL5152555 | 0.82 | CA1 (0.65) | KDM4EALDH1A1HSD17B10HPGDMAPT | |
| SCHEMBL8698365 | 0.82 | ALDH1A1 (0.65) | KDM4EALDH1A1HSD17B10HPGDMAPT | |
| SCHEMBL1730827 | 0.82 | ALDH1A1 (0.59) | KDM4EALDH1A1HSD17B10HPGDMAPT | |
| SCHEMBL6646528 | 0.81 | SLC6A4 (0.45) | KDM4EALDH1A1HSD17B10HPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11786890-B2 | Photo-redox titanium containing organic frameworks and methods of making and use thereof | FLORIDA STATE UNIVERSITY (US) | 2023-10-17 | — | — | US | disclosed |
| US-11786890-B2 | Photo-redox titanium containing organic frameworks and methods of making and use thereof | FLORIDA STATE UNIVERSITY (US) | 2023-10-17 | — | — | US | disclosed |
| US-20200188896-A1 | PHOTO-REDOX TITANIUM CONTAINING ORGANIC FRAMEWORKS AND METHODS OF MAKING AND USE THEREOF | NATIONAL SCIENCE FOUNDATION | 2020-06-18 | — | — | US | disclosed |
| US-5604292-A | Polymers with electrical and non-linear optical properties | THE UNTIED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1997-02-18 | — | — | US | disclosed |
| US-5587488-A | Bis-sulfonium salts of amino substituted bis(halomethyl) benzene | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1996-12-24 | — | — | US | disclosed |
| US-5585522-A | Amino substituted bishalomethyl benzene compounds | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1996-12-17 | — | — | US | disclosed |
| US-5578699-A | Process for making amino functional poly(para-phenylene vinylene)s | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1996-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11786890-B2 | Photo-redox titanium containing organic frameworks and methods of making and use thereof | PPOX, PPIF, CYBB | KDM4E 2531/4885ALDH1A1 616/4885HSD17B10 2970/4885 |
| US-20200188896-A1 | PHOTO-REDOX TITANIUM CONTAINING ORGANIC FRAMEWORKS AND METHODS OF MAKING AND USE THEREOF | PPOX, PPIF, CYBB | KDM4E 2531/4885ALDH1A1 616/4885HSD17B10 2970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.